Transplantation of the Heart and Both Lungs - Indications, Selection, and Evaluation
The successful clinical heart-lung transplantation by Reitz et al. , is a landmark in the annals of thoracic organ transplantation. Since 1981 over 1500 heart-lung transplants have been performed worldwide. The aim is to increase the life expectancy of severely ill patients with cardiopulmonary disease and to enhance their quality of life. To meet this aim, expert knowledge of the course of their disease and of the prospects for a successful transplant is necessary. Advances in surgical technique, organ preservation, and post-transplant care have improved survival and long-term graft function.
KeywordsPrimary Pulmonary Hypertension Severe Left Ventricular Dysfunction Progressive Pulmonary Disease Severe Tricuspid Valve Regurgitation Primary Pulmonary Hypertension Patient
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Reitz BA, Wallwork J, Hum SA. et al.
Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med. 1982;306:557.PubMedCrossRefGoogle Scholar
Hosenpud JD, Novick RJ, Breen TJ, Daily OP. The Registry of the International Society for Heart and Lung Transplantation: eleventh official report-1994. J Heart Lung Transplant. 1994;13:561.PubMedGoogle Scholar
Marshall SE, Kramer MR, Lewiston NJ, Starnes VA. Theodore J. Selection and evaluation of recipients for heart-lung and lung transplantation. Chest. 1990;98:1488.PubMedGoogle Scholar
Bolman RM, Shumway SJ, Estrin JA, Hertz MI. Lung and heart-lung transplantation: evolution and new applications. Ann Surg. 1991;214:456.PubMedCrossRefGoogle Scholar
Sarris GE, Smith JA, Shumway NE et al.
Long-term results of combined heart-lung transplantation: the Stanford experience. J Heart Lung Transplant. 1994;13:940.PubMedGoogle Scholar
D’Alonzo G, Barst RJ. Ayers SM et al.
Survival in patients with primary pulmonary hypertension. Ann Intern Med. 1991;115:343.PubMedGoogle Scholar
Ruhin LJ, Peter, RH. Oral hydralazine therapy for primary pulmonary hypertension. N Engl J Med. 1989;302:69.Google Scholar
Barst RJ, Rubin LJ, McGoon MD et al.
Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin. Ann Intern Med. 1994;121:409.PubMedGoogle Scholar
Kendall SWH, Wallwork J. Heart-lung transplantation: indications and technique. Semin Thorac Cardiovasc Surg. 1992;4:101.PubMedGoogle Scholar
Paluska PS, Bistrian BR, Benotti PN, Blackburn GL. The risks of surgery in obese patients. Ann Intern Med. 1986;104:540.Google Scholar
Abel RM, Fisher JE, Buckley MJ, Austen WG. Hyperalimentation in cardiac surgery: a review of sixty-four patients. J Thorac Cardiovasc Surg. 1974;67:294.PubMedGoogle Scholar
Lima O, Cooper JD, Peters WJ et al.
Effects of methylprednisnlone and azalhioprine on bronchial healing following lung autotransplantation. J Thorac Cardiovasc Surg. 1981;82:211.PubMedGoogle Scholar
Novick RJ, Menkis AH, McKenzie N et al.
The safety of low-dose prednisone before and immediately after heart-lung transplantation. Ann Thorac Surg. 1991;51:642.PubMedCrossRefGoogle Scholar
Jamieson SW, Stinson KB, Oyer PE et al.
Heart-lung transplanlalion for irreversible pulmonary hypertension. Ann Thorac Surg. 1984;38:554.PubMedCrossRefGoogle Scholar
Kramer MR, Tiroke A, Marshall S et al.
The clinical significance of hyperbilirubinemia in patients with pulmonary hypertension undergoing heart-lung transplant. J Heart Transplant. 1990:9:79A.Google Scholar
Yacoub MH, Banner NR, Khaghani A et al.
Combined heart and lung transplantation for cystic fibrosis and subsequent ‘domino’ cardiac transplant. J Heart Transplant. 1990;9:459.PubMedGoogle Scholar
© Kluwer Academic Publishers 1996